Skip to main content
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1995;22(4):347–348.

Losartan and angina pectoris.

S Ahmad 1
PMCID: PMC325288  PMID: 8605440

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer J. H., Reams G. P. The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs. Arch Intern Med. 1995 Jul 10;155(13):1361–1368. [PubMed] [Google Scholar]
  2. Goldberg M. R., Bradstreet T. E., McWilliams E. J., Tanaka W. K., Lipert S., Bjornsson T. D., Waldman S. A., Osborne B., Pivadori L., Lewis G. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension. 1995 Jan;25(1):37–46. doi: 10.1161/01.hyp.25.1.37. [DOI] [PubMed] [Google Scholar]
  3. Timmermans P. B., Wong P. C., Chiu A. T., Herblin W. F., Benfield P., Carini D. J., Lee R. J., Wexler R. R., Saye J. A., Smith R. D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993 Jun;45(2):205–251. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES